HLA-E Presents Glycopeptides from the Mycobacterium tuberculosis Protein MPT32 to Human CD8+ T cells

Melanie Harriff, Lisa M. Wolfe, Gwendolyn Swarbrick, Megan Null, Meghan E. Cansler, Elizabeth T. Canfield, Todd Vogt, Katelynne Gardner Toren, Wei Li, Mary Jackson, Deborah Lewinsohn, Karen M. Dobos, David Lewinsohn

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Infection with Mycobacterium tuberculosis (Mtb), the bacterium that causes tuberculosis, remains a global health concern. Both classically and non-classically restricted cytotoxic CD8+ T cells are important to the control of Mtb infection. We and others have demonstrated that the non-classical MHC I molecule HLA-E can present pathogen-derived peptides to CD8+ T cells. In this manuscript, we identified the antigen recognized by an HLA-E-restricted CD8+ T cell clone isolated from an Mtb latently infected individual as a peptide from the Mtb protein, MPT32. Recognition by the CD8+ T cell clone required N-Terminal O-linked mannosylation of MPT32 by a mannosyltransferase encoded by the Rv1002c gene. This is the first description of a post-Translationally modified Mtb-derived protein antigen presented in the context of an HLA-E specific CD8+ T cell immune response. The identification of an immune response that targets a unique mycobacterial modification is novel and may have practical impact in the development of vaccines and diagnostics.

Original languageEnglish (US)
Article number4622
JournalScientific Reports
Volume7
Issue number1
DOIs
StatePublished - Dec 1 2017

Fingerprint

Glycopeptides
Mycobacterium tuberculosis
T-Lymphocytes
Proteins
Mannosyltransferases
Clone Cells
Peptides
Mycobacterium Infections
Tuberculosis
Vaccines
Bacteria
Antigens
Infection
Genes

ASJC Scopus subject areas

  • General

Cite this

HLA-E Presents Glycopeptides from the Mycobacterium tuberculosis Protein MPT32 to Human CD8+ T cells. / Harriff, Melanie; Wolfe, Lisa M.; Swarbrick, Gwendolyn; Null, Megan; Cansler, Meghan E.; Canfield, Elizabeth T.; Vogt, Todd; Toren, Katelynne Gardner; Li, Wei; Jackson, Mary; Lewinsohn, Deborah; Dobos, Karen M.; Lewinsohn, David.

In: Scientific Reports, Vol. 7, No. 1, 4622, 01.12.2017.

Research output: Contribution to journalArticle

Harriff, M, Wolfe, LM, Swarbrick, G, Null, M, Cansler, ME, Canfield, ET, Vogt, T, Toren, KG, Li, W, Jackson, M, Lewinsohn, D, Dobos, KM & Lewinsohn, D 2017, 'HLA-E Presents Glycopeptides from the Mycobacterium tuberculosis Protein MPT32 to Human CD8+ T cells', Scientific Reports, vol. 7, no. 1, 4622. https://doi.org/10.1038/s41598-017-04894-0
Harriff, Melanie ; Wolfe, Lisa M. ; Swarbrick, Gwendolyn ; Null, Megan ; Cansler, Meghan E. ; Canfield, Elizabeth T. ; Vogt, Todd ; Toren, Katelynne Gardner ; Li, Wei ; Jackson, Mary ; Lewinsohn, Deborah ; Dobos, Karen M. ; Lewinsohn, David. / HLA-E Presents Glycopeptides from the Mycobacterium tuberculosis Protein MPT32 to Human CD8+ T cells. In: Scientific Reports. 2017 ; Vol. 7, No. 1.
@article{f2903fd3d92642bb97eaad07f7515796,
title = "HLA-E Presents Glycopeptides from the Mycobacterium tuberculosis Protein MPT32 to Human CD8+ T cells",
abstract = "Infection with Mycobacterium tuberculosis (Mtb), the bacterium that causes tuberculosis, remains a global health concern. Both classically and non-classically restricted cytotoxic CD8+ T cells are important to the control of Mtb infection. We and others have demonstrated that the non-classical MHC I molecule HLA-E can present pathogen-derived peptides to CD8+ T cells. In this manuscript, we identified the antigen recognized by an HLA-E-restricted CD8+ T cell clone isolated from an Mtb latently infected individual as a peptide from the Mtb protein, MPT32. Recognition by the CD8+ T cell clone required N-Terminal O-linked mannosylation of MPT32 by a mannosyltransferase encoded by the Rv1002c gene. This is the first description of a post-Translationally modified Mtb-derived protein antigen presented in the context of an HLA-E specific CD8+ T cell immune response. The identification of an immune response that targets a unique mycobacterial modification is novel and may have practical impact in the development of vaccines and diagnostics.",
author = "Melanie Harriff and Wolfe, {Lisa M.} and Gwendolyn Swarbrick and Megan Null and Cansler, {Meghan E.} and Canfield, {Elizabeth T.} and Todd Vogt and Toren, {Katelynne Gardner} and Wei Li and Mary Jackson and Deborah Lewinsohn and Dobos, {Karen M.} and David Lewinsohn",
year = "2017",
month = "12",
day = "1",
doi = "10.1038/s41598-017-04894-0",
language = "English (US)",
volume = "7",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - HLA-E Presents Glycopeptides from the Mycobacterium tuberculosis Protein MPT32 to Human CD8+ T cells

AU - Harriff, Melanie

AU - Wolfe, Lisa M.

AU - Swarbrick, Gwendolyn

AU - Null, Megan

AU - Cansler, Meghan E.

AU - Canfield, Elizabeth T.

AU - Vogt, Todd

AU - Toren, Katelynne Gardner

AU - Li, Wei

AU - Jackson, Mary

AU - Lewinsohn, Deborah

AU - Dobos, Karen M.

AU - Lewinsohn, David

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Infection with Mycobacterium tuberculosis (Mtb), the bacterium that causes tuberculosis, remains a global health concern. Both classically and non-classically restricted cytotoxic CD8+ T cells are important to the control of Mtb infection. We and others have demonstrated that the non-classical MHC I molecule HLA-E can present pathogen-derived peptides to CD8+ T cells. In this manuscript, we identified the antigen recognized by an HLA-E-restricted CD8+ T cell clone isolated from an Mtb latently infected individual as a peptide from the Mtb protein, MPT32. Recognition by the CD8+ T cell clone required N-Terminal O-linked mannosylation of MPT32 by a mannosyltransferase encoded by the Rv1002c gene. This is the first description of a post-Translationally modified Mtb-derived protein antigen presented in the context of an HLA-E specific CD8+ T cell immune response. The identification of an immune response that targets a unique mycobacterial modification is novel and may have practical impact in the development of vaccines and diagnostics.

AB - Infection with Mycobacterium tuberculosis (Mtb), the bacterium that causes tuberculosis, remains a global health concern. Both classically and non-classically restricted cytotoxic CD8+ T cells are important to the control of Mtb infection. We and others have demonstrated that the non-classical MHC I molecule HLA-E can present pathogen-derived peptides to CD8+ T cells. In this manuscript, we identified the antigen recognized by an HLA-E-restricted CD8+ T cell clone isolated from an Mtb latently infected individual as a peptide from the Mtb protein, MPT32. Recognition by the CD8+ T cell clone required N-Terminal O-linked mannosylation of MPT32 by a mannosyltransferase encoded by the Rv1002c gene. This is the first description of a post-Translationally modified Mtb-derived protein antigen presented in the context of an HLA-E specific CD8+ T cell immune response. The identification of an immune response that targets a unique mycobacterial modification is novel and may have practical impact in the development of vaccines and diagnostics.

UR - http://www.scopus.com/inward/record.url?scp=85021707596&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021707596&partnerID=8YFLogxK

U2 - 10.1038/s41598-017-04894-0

DO - 10.1038/s41598-017-04894-0

M3 - Article

VL - 7

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 4622

ER -